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This study aimed to assess the potential anti-angiogenic mechanism of Phyllanthus urinaria (P. urinaria) and characterize the
major compound in P. urinaria that exerts anti-angiogenic eﬀect. The water extract of P. urinaria and Ellagic Acid were used to
evaluate the anti-angiogenic eﬀect in chorioallantoic membrane (CAM) in chicken embryo and human vascular endothelial cells
(HUVECs). The matrix metalloproteinase-2 (MMP-2) activity was determined by gelatin zymography. The mRNA expressions of
MMP-2, MMP-14 and tissue inhibitor of metalloproteinase-2 (TIMP-2) were analyzed by reverse transcription polymerase chain
reaction (RT-PCR). Level of MMP-2 proteins in conditioned medium or cytosol was determined by western blot analysis. We
conﬁrmed that P. urinaria’s in vivo anti-angiogenic eﬀect was associated with a reduction in MMP-2 activity. Ellagic acid, one of
the major polyphenolic components as identiﬁed in P. urinaria by high performance liquid chromatography mass spectrometry
(HPLC/MS), exhibited the same anti-angiogenic eﬀect in vivo.B o t hP. urinaria and Ellagic Acid inhibited MMP-2 activity in
HUVECs with unchanged mRNA level. The mRNA expression levels of MMP-14 and TIMP-2 were not altered either. Results from
comparing the change of MMP-2 protein levels in conditioned medium and cytosol of HUVECs after the P. urinaria or Ellagic
Acid treatment revealed an inhibitory eﬀect on the secretion of MMP-2protein. This study concluded that Ellagic Acid is the active
compound in P. urinaria to exhibit anti-angiogenic activity and to inhibit the secretion of MMP-2 protein from HUVECs.
1.Introduction
Phyllanthus urinaria, one of the herbal plants belonging to
the genus Phyllanthus (Euphorbiaceae), is widely distributed
in China, Southern India and South America. It has been
used clinically in Asia to treat diarrhea, dysentery, hepatitis,
edema, infantile malnutrition, acute conjunctivitis, aphthae
and antibiotic resistant pyogenic infections [1, 2]. In our
previous studies, water extracts prepared from P. urinaria
were found to be cytotoxic to several tumor cell lines and
the eﬀects were mediated through the induction of apoptosis
as the result of the up-regulation of Fas, FasL and Bax gene
expression and the downregulation of Bcl-2 gene expression
[3–5].Cellculturestudiesalsodemonstratedthatendothelial
cell migration and matrix-induced tube formation in human
vascular endothelial cell (HUVEC) system were inhibited
[6]. We also reported the anti-angiogenic eﬀect of P.
urinaria in mice bearing Lewis lung carcinoma [6]. Various
polyphenolic compounds with antioxidant eﬀect have been
identiﬁed in P. urinaria [7]; however, which polyphenolic
compound may potentially contribute to the anti-angiogenic
eﬀect of P. urinaria is not clear.
Angiogenesis, an important aspect necessary for tumor
development,proceedsthroughaseriesofstepsincludingthe
early degradation of extracellular matrix (ECM) predomi-
nantly by matrix metalloproteinases (MMPs), migration and
proliferation of vascular endothelial cells, and maturation of
the new blood vessel in response to local factors [8]. MMPs2 Evidence-Based Complementary and Alternative Medicine
are a growing family of Zn-dependent matrix proteases,
which are key mediators of ECM remodeling. MMPs not
only are involved in the removal of structural proteins in the
ECM, but also indirectly control multiple cellular functions
including cell growth, apoptosis, angiogenesis, invasion and
metastasis through its proteolytic action on growth factors,
cell adhesion molecules and other bioactive proteins [9].
The present study demonstrated that P. urinaria could
reduce MMP-2 activity in chick chorioallantoic membrane
(CAM) assay and in HUVECs, which was one potential
mechanism for its anti-angiogenic eﬀect. The key active
compound in the P. urinaria extract, which exerts its anti-
angiogenic eﬀect, was also identiﬁed.
2. Methods
2.1. Preparation of P. urinaria Extracts. P. urinaria used in
this study was identiﬁed based on the deﬁnition described
in Flora of Taiwan [10] and authenticated by Dr Rong-
Chi Yang, the chief of the Chinese Herbal Pharmacy in
Chang Gung Memorial Hospital. A sample of P. urinaria
is deposited in set D, TN: No 173156 in the herbarium
of National Taiwan University. The extract was prepared
according to Taiwanese good manufacturing practice (GMP)
methodologies and guidelines. Brieﬂy, the whole plant was
minced and extracted with boiling water 1:20 (w/v) for 4h;
then, the extract was removed and water, 1:20 (w/v), was
again added and boiled for 4h. The resulting crude extract
was ﬁltered and lyophilized down to a dry powder. The
extract used in the experiments was prepared by dissolving
the powder in sterile water at the desired concentration and
storingat −20◦C.Theextractionratewas26.4%,thatis,1gm
of lyophilized powder is equal to 3.79gm original herb.
2.2. Mass Spectrometry. High performance liquid chro-
matography (HPLC) was performed on Shimadzu SIL-
20A LITE (Shimadzu Corporation, Columbia, MD, USA).
Shimadzu SPD-10AVP UV-Vis Detector was used at λ =
270nm. The chromatographic separation was carried out on
an Agilent Zorbax Eclipse XD8-C18 column (4.6 × 150mm
i.d.; 3.5μm particle size) eluted with the mixture of 0.01%
triﬂuoroacetic acid(aq) (A) and acetonitrile (B). The linear
g r a d i e n tp r o g r a mw a ss e tf r o m9 5:5( A:B ,v / v )t o8 0:2 0i n
22min, then the concentration of acetonitrile was increased
from 20 to 30% in the following 28min. Flow rate was
0.6mLmin−1. Sample injecting volume was 30μl each. Mass
spectra were acquired using a LTQ XL Mass Spectrometer
(Thermo Electron Corp, San Jose, CA, USA) equipped with
an electrospray ionization source operated in the negative
mode using the following conditions: Spray voltage (4.5kV);
heated capillary temperature (245◦C); capillary voltage 47V;
tube lens oﬀset (5.25V). Nitrogen was used as the sheath
and auxiliary gas at 35 and 10 units, respectively. Mass
spectrometry (MSn) experiments were carried out using
Helium as collision gas. Data acquisition and analysis were
accomplished with Xcalibur software version 2.0 (Thermo
Electron Corp.). Gallic acid and Ellagic Acid (Sigma-Aldrich
Corporation, WI, USA) were used as reference compounds
and dissolved separately in methanol (MeOH).
2.3. Glucuronidation Metabolites of P. urinaria Extract. The
glucuronidation metabolites of water extract of P. urinaria
were measured by treating with β-glucuronidase for glu-
curonide hydrolysis. An aliquot of 100μL P. urinaria extract
(100mgmL−1) was titrated with HCl (10N) to pH 1-2 and
incubated for 1h at 37◦C and again titrated with NaOH
( 1 0N )b a c kt op H6 . 8 .A na l i q u o to f1μLo fβ-glucuronidase
(134.60 unitsmL−1) was added into a portion of 20μl
P. urinaria extract and 80μL Tris (100mM, pH 6.8) and
then incubated at 37◦C for 2h. Control incubations in the
presence and absence of HCl without β-glucuronidase were
performedsimultaneously.Afterincubation,a3-foldvolume
of acetonitrile/methanol (2:1) was added to the samples
followed by vortex mixing, centrifugation and ﬁltration. The
ﬁltrate (20μL) was injected onto the HPLC system.
2.4. Cell Culture. HUVECs were isolated from the vein of
human umbilical cords and grown in EGM provided by
Clonetics (MD, USA). Cells were maintained in a humidiﬁed
atmosphere with 5% CO2/95% air at 37◦C and passaged 3–5
times prior to use in experiments. To examine the eﬀect of P.
urinaria extract on cell function, cells at 80–90% conﬂuency
were treated with 0–2mgmL−1 of P. urinaria extract or 0–
10μM Ellagic Acid for 24h.
2.5. CAM Angiogenesis Aassay. Angiogenesis assays were
performed on the CAMs of 10-day-old chick embryos with
minor modiﬁcations [11]. First, a small hole was made
through the shell at the air sac end of the chick egg using a
small craft drill. A second hole was drilled on the broad side
of the egg directly over embryonic blood vessels. Negative
pressure was applied to the original hole, resulting in the
CAM pulling away from the shell membrane, creating a
false air sac. A window was cut through the shell over the
dropped CAM and saturated with 100μL of sterile 1 × PBS
(phosphate buﬀer solution) containing 120ng phorbol-12-
myristate-13-acetate (PMA) in the presence or absence of
P. urinaria or Ellagic Acid. Sterile 1 × PBS was used for
the control egg. The shells were covered with adhesive tape
and incubated in a 37◦C incubator. After 48h, the CAM
tissues were harvested and examined for angiogenesis under
a stereomicroscope (Zeiss, Germany). The angiogenic index
was deﬁned as the mean number of visible blood vessel
branch points within the deﬁned area of the membrane.
Photographs were taken at 16x magniﬁcation.
2.6. Zymography Analysis. CAM harvested from the egg was
homogenized in 1 × PBS. The supernatant was collected
after brief centrifugation and used for the analysis of MMP
activity. Conditioned media collected from cultured human
endothelial cells with 24-h treatment with P. urinaria or
EllagicAcidwerealsoprocessedforanalysisoftheirinﬂuence
on MMP activity. Protein samples were loaded onto 10%
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) gels in which 1% gelatin (Amersham Life
Science, Cleveland, OH, USA) was incorporated [12]. After
migration, gels were incubated with 2.5% Triton-X 100
twice for 30min at room temperature, washed for 5min inEvidence-Based Complementary and Alternative Medicine 3
TNCA (50mM Tris pH 7.5, 200mM NaCl, 5mM CaCl2)
and further incubated for 16h in TNCA in a shaking
bath at 37◦C. Gels were stained for 1h in coomassie blue
(0.1% coomassie brillant blue R-250, 50% methanol, 10%
acetic acid) and destained in 5% methanol/9% acetic acid
until proper contrast was achieved. White bands on blue
background indicated zones of digestion corresponding to
the presence of diﬀerent MMPs.
2.7. RNA Isolation and Reverse Transcription Polymerase
Chain Reaction. Total cellular RNA was isolated by lysis of
cells in a guanidinium isothiocyanate buﬀer, followed by
single step phenol-chloroform-isoamyl alcohol extraction
procedure modiﬁed from that previously described [13].
Brieﬂy, P.urinariaorEllagicAcidofuntreatedortreatedcells
wereharvestedandlysedin4Mguanidiniumisothiocyanate,
25mM sodium citrate (pH 7.0), 0.5% sodium sarkosine
and 0.1M β-mercaptoethanol. Sequentially, 1/10 volume
of 2M sodium acetate (pH 4.0), one volume of phenol
and 1/5 volume of chloroform-isoamyl alcohol (49:1, v:v)
were added to the homogenate. After vigorous vortexing
for 30s, the solution was centrifuged at 10000g for 15min
at 4◦C. After removal of the aqueous phase, RNA was
precipitated by the addition of 0.5mL isopropanol. One
μg of total RNA was reverse-transcribed into cDNA by
incubating with 200 units of reverse transcriptase in 20μL
of reaction buﬀer containing 0.25μgo fr a n d o mp r i m e r s
and 0.8mM dNTPs at 42◦C for 60min. Two microliters
o fc D N Aw a su s e da st e m p l a t ef o rt h eP C Rr e a c t i o n .P C R
was performed in buﬀer containing 10mM Tris, pH 8.3,
50mM KCl, 1.5mM MgCl2, 0.2mM dNTPs, 1μMo fe a c h
primer and 5 units Taq DNA polymerase for 30 cycles
of denaturation at 94◦C for 1min, annealing at 55◦Cf o r
1min and extension at 72◦C for 2min. The resulting PCR
product was analyzed by ethidium bromide (EtBr) stained
1.5% agarose gel electrophoresis. Sequences for the speciﬁc
primers used in the PCR are MMP-2 forward primer
(5 -GTTTCCATTCCGCTTCCAGG-3 )a n dr e v e r s ep r i m e r
(5 -TGCCCTTGATGTCATCCTGG-3 ); MMP-14 forward
primer (5 -ACATACGAGGCCATTCGCAA-3 )a n dr e v e r s e
primer (5 -TCCTTGAAGACAAACATCTCCCC-3 ); TIMP-
2 forward primer (5 -ACAGGCGTTTTGCAATGCAG-3 )
and reverse primer (5 -CGCGCAAGAACCATCACTTC-3 );
GAPDHforwardprimer(5 -TTCATTGACCTCAACTACAT-
3 )a n dr e v e r s ep r i m e r( 5  -GAGGGGCCATCCACAGTCTT-
3 ).
2.8. Western Blotting. Protein concentrations were deter-
mined by the Bradford method (Bio-Rad, CA, USA). Sam-
ples with equal amount of proteins were subjected to 10%
SDS-PAGE and transferred onto a polyvinylidene diﬂuoride
(PVDF) (Millipore, Bedford, MA, USA) membrane. The
membrane was incubated at room temperature in blocking
solution (1% bovine serum albumin (BSA), 1% goat serum
in PBS) for 1h, followed by 2h incubation in blocking solu-
tion containing an appropriate dilution (1:1000) of primary
antibody, for example, anti-MMP-2 antibody (NeoMarkers,
Fremonk, CA, USA). After washing, the membrane was
incubatedinPBScontaininggoatanti-mouseIgGconjugated
with horseradish peroxidase (Sigma, St Louis, MO, USA) for
1hour. The membrane was washed and the positive signals
were developed with chemiluminescence reagent (Amer-
sham Pharmacia Biotech, Little Chalfont Buckinghamshire,
England). Membrane was exposed to Fuji medical X-ray ﬁlm
(Fuji Ltd, Tokyo, Japan) for 30min.
2.9. Statistical Aanalysis. All statistical analyses were per-
formed using SigmaStat statistical software (version 2.0,
Jandel Scientiﬁc, CA, USA). Results were represented as
means ± standard deviation (SD). ANOVA was carried out
when multiple comparisons were evaluated. Values were
considered to be signiﬁcant at P<. 05. All experiments were
repeated at least three times independently.
3. Results
3.1. P. urinaria Extract Inhibited In Vivo Angiogenesis and
MMP-2 Activity on CAMs of Chicken Embryos. We ﬁrst used
theCAMassaytostudytheinvivoeﬀectofP.urinariaextract
on PMA-induced angiogenesis. As shown in Figure 1(a), the
vessels in the control CAM treated with 1 × PBS only were
small and less branched than the newly spouting vessels
induced by PMA under stereomicroscopic observation. The
angiogenic response was eﬀectively inhibited by the addition
of P. urinaria extract. Addition of 0.5 and 2mgmL−1 of P.
urinaria extracts lead to a decrease of 24 and 74% in the
angiogenic index as determined by counting the number
of blood vessel branch points (Figure 1(b)). These results
conﬁrm the inhibitory eﬀect of P. urinaria extract on in
vivo angiogenesis. To further investigate the underlying
molecular mechanism, we performed gelatin zymography to
analyze the MMP activity in protein samples prepared from
CAMs after P. urinaria treatment. The dominant gelatin-
type of MMP from CAMs was MMP-2, whereas MMP-9
was minimally present. PMA could induce MMP-2 activity
and correlated well with the induction of angiogenesis. In
the presence of aqueous extract of P. urinaria, PMA-induced
MMP-2activity wassuppressedinadose-dependent manner
(Figure 1(c)).
3.2. Chemical Chromatography of the Aqueous Extract of
P. urinaria. Analysis of the water extracts of P. urinaria
by HPLC led to the identiﬁcation of twelve compounds
as shown in Figure 2(a). The mass structures of these
compounds were tentatively assigned based on their mass
data mining from existing literature. The mass of peak
1( Rt at 5.8min) was determined to be 170 by liquid
chromatography electrospray ionisation tandem mass spec-
trometry (LC/(−)ESI-MS), yielding [M–H]− at m/z 169.
The major fragment was shown at m/z 151 (M–H–H2O)
and 125 (M–COOH), consistent with the structure of gallic
acid (Figure 3)[ 14]. The mass of peak 3 (Rt at 18.0min)
and peak 9 (Rt at 23.3min) were determined to be 292
and 248, yielding [M–H]− at m/z 291 and 247, respectively.
The major fragment of peak 3 was shown at m/z 247 (M–
COOH), and the minor fragment ions were the same as peak
9. Thus, the determined mass of peak 3 is 44 higher than
peak 9, suggesting a carboxylic acid derivative of peak 9.4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Phyllanthus urinaria extract inhibited the in vivo angiogenesis and MMP-2 activity induced on the CAMs of chicken embryos.
(a) Representative photos of CAMs at the end of experiment. (b) Angiogenic index was quantiﬁed by counting the number of blood vessel
branch points on each CAM. (c) Decreased MMP-2 activity in P. urinaria treated chorioallantoic memebranes. The protein extract was
prepared by homogenizing the CAMs, centrifuging and using the resulting supernatant for gelatin zymography analysis. Bar value is the
mean ± SD of three independent experiments. Asterisk means statistic signiﬁcance in comparison with the vehicle control.
By searching the bioactive components previously found in
Phyllanthus species [14, 15], peak 3 and peak 9 were assigned
to be brevifolin carboxylic acid and brevifolin, respectively
(Figure 3). LC/(−)ESI-MS analysis of peak 4 (Rt at 19.0min)
producedthesame[M–H]− atm/z 291withpeak3.Collision
activated decomposition mass spectrum [(−)CAD-MS/MS]
analysis of peak 4 yielded intense product ions at m/z
247 (M–COOH), 203 (M–2COOH). Compared with the
mass and mass fragments of compounds found in other
Phyllanthus species, the structure of peak 4 was assigned to
be phyllanthusiin E (Figure 3)[ 16]. LC/(−)ESI-MS analysis
of peak 5 (Rt at 19.5min), peak 6 (Rt at 20.5min), peak 7 (Rt
at21.2min),peak8(Rt at22.8min),peak10(Rt at24.2min)
and peak 11 (Rt at 24.6min) yielded [M–H]− at m/z 633,
951, 953, 925, 969 and 924, respectively. (−)CAD-MS/MS
analysis of all these components yielded intense product
ions at m/z 633 and 301, resulting from the loss of the
hexahydroxydiphenoyland/orgalloylmoietyfragments[17].
These ions are signiﬁcant fragments of ellagitannins. After
comparing the mass and other minor fragment ions with
tannins found in other Phyllanthus species, the structures
of these peaks were assigned to be corilagin [14, 17],
geraniin [18], chebulagic acid [19], phyllanthusiin C [20],
phyllanthusiin B [20] and phyllanthusiin U [14], respectively
(Figure 3). Peak 2 (Rt at ∼14.0min) produced a same [M–
H]− at m/z 633 with peak 5. The fragment ions at m/z 453
(M-H-Gal) and 301 (M-H-Gal-glc), corresponding to peak
5, are consistent with the structure of isostrictiniin [21].
Peak 12 (Rt at 28.7min) yielded a [M–H]− at m/z 301,
consistent with a mass of 302. The same fragment pattern
was shown by comparing (−)CAD-MS/MS analysis of peak
12 with the product ion spectral analysis of the fragment
ion at m/z 301 (MS3) in peak 5 (corilagin). The information
suggested an Ellagic Acid moiety and compared with the
fragments with literature [14], peak 12 was assigned to be
Ellagic Acid (Figure 3). The identities of peaks 1 and 12 were
further conﬁrmed by chemical markers (Mass and its HPLC
retention times) to be gallic and Ellagic Acid, respectively.
Based on standard curve of mass unit versus the amount of
standards, the amounts of gallic and Ellagic Acid found in
P. urinaria in the present study were 3.09 ± 0.17 and 2.67 ±
0.16mgg−1 DW, respectively.Evidence-Based Complementary and Alternative Medicine 5
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Figure 2:HPLCchromatogramsof(a)P.urinariawaterextractand
(b)P.urinariawaterextracttreatedwithHCLaloneor(c)withHCL
following β-glucuronidase treatment monitored at 270nm.
After pH 1-2 treatment of P. urinaria, to mimic gastric
pH,therewerenospeciﬁcchanges(Figure 2(b))inthechem-
ical proﬁle compared to untreated P. urinara (Figure 2(a)).
Sinceintestineandcolonhaveanaerobicbacteria,whichhave
β-glucuronidase activity capable of digesting glucuronides
found in herbal extract, P. urinaria aqueous extract was
further treated with E. coli β-glucuronidase. There was
substantial change of chemical ﬁngerprint of P. urinaria.
The amounts of compound 3 and 12 (Ellagic Acid) were
not altered much (Figure 2(c)). Meanwhile, gallic acid was
hydrolyzed completely after neutralizing to pH 6.8 using
NaOH from pH1-2 treatment and incubated at a tempera-
ture of 37◦C (data not shown).
3.3. Ellagic Acid In Vivo Inhibited Angiogenesis and MMP-
2 Activity on CAMs of Chicken Embryos. Ellagic acid, being
resistant to pH 1-2 and E. coli β-glucuronidase treatment,
was shown by others to inhibit angiogenesis in vitro [22]. We
therefore examined the eﬀect of Ellagic Acid in comparison
with aqueous extract of P. urinaria by CAM assay. As shown
in Figure 4(a), PMA-induced angiogenesis was eﬀectively
inhibited by the addition of Ellagic Acid. Addition of
5a n d1 0 μM Ellagic Acid resulted in a decrease of the
angiogenic index by 62 and 83%, respectively (Figure 4(b)).
Additionally, gelatin zymography demonstrated that MMP-
2 activity induced by PMA from CAM was also inhibited
(Figure 4(c)) by Ellagic Acid in a dose-dependent manner.
The potency of Ellagic Acid is equivalent to its amount in P.
urinaria aqueous extract.
3.4. Inhibition of MMP-2 Activity, but Not MMP-2, 14 and
Tissue Inhibitor of Metalloproteinase-2 Gene Expression by P.
urinaria and Ellagic Acid In Vitro. To further examine the
potentialmechanismunderlyingtheanti-angiogeniceﬀectof
P. urinaria in an in vitro cell model, we tested the eﬀect of P.
urinariaonMMP-2activityinHUVECs.Resultsfromgelatin
zymography revealed that the inhibitory eﬀect of P. urinaria
or Ellagic Acid on MMP-2 activity also occurred in cultures
of HUVECs (Figures 5(a) and 6(a)) dose-dependently with
the potency of Ellagic Acid about the same as that in aqueous
extract of P. urinaria.
It is known that multiple regulatory mechanisms are
involved in the modulation of MMP-2 expression and activ-
ity. We examined whether P. urinaria or Ellagic Acid could
aﬀecttheMMP-2geneexpressionatthetranscriptionallevel.
As shown in Figures 5(b) and 6(b), the expression of MMP-2
mRNA remained unchanged after the P. urinaria or Ellagic
Acid treatment. The other two mRNAs, including MMP-14
and TIMP-2, known to play important roles in regulating the
MMP-2activity,werealsonotalteredbyP.urinariaorEllagic
Acid treatment either.
3.5. Inhibition of MMP-2 Secretion in HUVECs by P. urinaria
and Ellagic Acid. The process of MMP-2 secretion to the
extracellular environment where it actually functions could
be another critical mechanism for the regulation of angio-
genesis. As shown in Figures 5(c) and 6(c), the protein levels
of MMP-2in conditioned medium after P.urinariaor Ellagic
Acid treatment were dose-dependently decreased and corre-
lated well with the decrease of MMP-2 activity as analyzed by
gelatinzymography.Interestingly,theproteinlevelsofMMP-
2 in the cytosol were conversely increased after P. urinaria or
Ellagic Acid treatment in a dose-dependent manner (Figures
5(c) and 6(c)). The accumulation of MMP-2 protein in the
cytosol and the decrease of MMP-2 protein in conditioned
mediumindicatedthatatargetwasinvolvedintheinhibition
ofsecretorypathwayofMMP-2byP.urinariaorEllagicAcid.
4. Discussion
Angiogenesis, the formation of new blood vessels to supply
enough nutrition and oxygen to a local environment [23],
is known to play an important role in several physiological
and pathological processes [24, 25]. The primary step
in the angiogenic process relies on the degradation of6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Structures of the identiﬁed compounds in P. urinaria extract.
subendothelial basement membrane and surrounding ECM
proteins [26]. MMPs, which degrade ECM proteins, are
involved in angiogenesis both in vitro [27]a n din vivo
[28]. Therefore, inhibition on the early degradation of
ECM proteins predominantly by MMPs is considered an
important strategy to inhibit angiogenesis. In this study,
we attempted to further clarify potential mechanism under-
lying the anti-angiogenic eﬀect of P. urinaria, which was
discovered previously in our laboratory [6]. Results from
the in vivo CAM assay showed that P. urinaria eﬃciently
inhibited embryonic angiogenesis and the MMP-2 activity
in the protein extract prepared from CAM. This suggested
that the inhibition of angiogenesis in chicken embryo by
P. urinaria could be a result, in part, from the failure
of vascular endothelial cells to degrade the surrounding
ECM and therefore impede the following migration and
proliferation. Among the various MMPs (MMP-1, -2, -9, -
13 and -14) produced by vascular endothelial cells including,
MMP-2 and MMP-14 (MT1-MMP) have been linked to cell
invasion and network formation [29, 30]. The inhibition
of MMP-2 activity was shown to be capable of disrupting
the tube formation of endothelial cells [31], which may also
explain our previous ﬁnding that P. urinaria could inhibit
the matrix-induced tube formation of vascular endothelial
cells.
In recent years, extract from natural products such as
propolis and bilberry [32, 33] exhibited anti-angiogenic
eﬀect through suppression of ERK1/2 phosphorylation.
However, the exact compound from propolis and bilberry
responsible for anti-angiogenesis is not clear. In order to
furtheridentifywhichcompoundsinP.urinariaextractexert
their anti-cancer eﬀect through angiogenic pathways, we
characterized 12 polyphenolic compounds from P. urinaria
that were recognized by HPLC and LC/MS. The major com-
pound in P. urinaria was corilagin followed by gallic acid and
Ellagic Acid. Herein, the ﬁngerprint proﬁle of P. urinaria can
be used for plant identiﬁcation and batch-to-batch quality
control. In addition, we found that 8.33 ± 0.49μMo fE l l a g i c
Acid was equal to 1mgmL−1 of P. urinaria in water extract
as demonstrated by in vivo and in vitro anti-angiogenesis
assays. Ellagic Acid (4,4 ,5,5 6,6 -hexahydroxydiphenic acid
2,6,2 ,6 -dilactone) is a natural phenolic constituent present
in woody plants, berries, grapes and nuts [34]. Ellagic
Acid has been reported to show many biological proper-
ties including antioxidant, antiproliferative and apoptosis-
inducing activities [35]. Recently, the anticancer eﬀect ofEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Ellagic Acid inhibited the in vivo angiogenesis and MMP-2 activity induced on the CAMs of chicken embryos. (a) Representative
photos of CAMs at the end of experiment. (b) Angiogenic index was quantiﬁed by counting the number of blood vessel branch points
on each CAM. (c) Decreased MMP-2 activity in Ellagic Acid treated chorioallantoic memebranes. The protein extract was prepared by
homogenizing the CAMs, centrifuging and using the resulting supernatant for gelatin zymography analysis. Bar value is the mean ± SD of
three independent experiments. Asterisk means statistic signiﬁcance in comparison with the vehicle control.
Ellagic Acid on the angiogenic process was studied in vitro
and found to inhibit migration and tube formation by
downregulation of both PDGF and VEGF receptors [22]. In
report by Losso et al. [36], they suggested that inhibition of
cancer cell proliferation by Ellagic Acid could be mediated
by regulation of MMPs, VEGF and induction of apoptosis in
cancer cells, but not normal cells. According to the report
of Talcott et al. [37], 5–10μmolL−1 of Ellagic Acid in cell
culture could be a physiological concentration in the blood
plasma after food consumption. In our study, we further
conﬁrm the observations of others. In chicken embryos
treated with P. urinaria (1-2mgmL−1) or Ellagic Acid (5–
10μM),ananti-angiogensiseﬀectwasobservedandcouldbe
due to the inhibition of MMP-2 activity. HUVECs exposed
to similar P. urinaria or Ellagic Acid concentrations as the
CAM demonstrated the same suppressive eﬀect of MMP-2
activity in HUVECs. In a bioavailability study using wild-
type mice [38], Ellagic Acid was detectable in the plasma
level with oral feeding of ellagitannins to mice. In our study,
digestive-mimicking treatments of HCl pH 1-2 followed
by exposure to β-glucuronidase, eﬀectively changed most
compoundsexceptforEllagicAcid.ThissuggestsEllagicAcid
will survive digestion and be available for absorption into
circulation. From these studies, we conclude that the main
activeconstituentofP.urinariaforits antiangiogenic activity
in vivo is Ellagic Acid.
MMP-2 activity is known to be regulated at multiple
levels [39]. The MMP-2 promoter is constitutively active
in endothelial cells, which is seldom inducible by growth
factors or cytokines, although some exceptions exist in other
cell lines [40]. Our results showed that the inhibitory eﬀect
of P. urinaria or Ellagic Acid on MMP-2 activity was not
at the transcriptional level. Another important regulatory
mechanism for the activation of MMP-2, mediated by
MMP-14, occurs mainly at the cell surface. Latent pro-
MMP-2 is activated on the cell surface by MMP-14 in a
process regulated by the tissue inhibitor of metalloproteinase
(TIMP)-2 [41, 42]. Under physiological conditions, MMP-
14, free of TIMP-2, can activate complex ternary pro-MMP-
2. Since the ratio between the amounts of pro-MMP-2
and active MMP-2 as shown in zymography data did not
change upon the treatment with either P. urinaria or Ellagic
Acid. Both the amounts of pro-MMP-2 and active MMP-
2 decreased in parallel and dose-dependently after drug8 Evidence-Based Complementary and Alternative Medicine
M: medium only
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Figure 5: (a) Phyllanthus urinaria extract dose-dependently inhib-
ited the MMP-2 activity in HUVECs. Conditioned media taken
from cultures of HUVECs, with or without the treatment of P.
urinaria extract for 24h, were used for the gelatin zymography
analysis. To study the eﬀects of P. urinaria extract on the mRNA
expression of MMP in HUVECs, cells were treated with (b) P.
urinaria for 24h and the mRNA expressions of MMP-2, MMP-
14, TIMP-2 and GAPDH were determined by RT-PCR analysis. (c)
Cells treated with P. urinaria for 24h were processed for western
blotting to analyze the protein levels of MMP-2 in the conditioned
media and cytosol.
treatment. It indicated that the activation of pro-MMP-
2 toward active MMP-2 was not aﬀected by P. urinaria
and Ellagic Acid. There is, therefore, a close relationship
between MMP-2 activation through the interactions of pro-
MMP-2, MMP14and TIMP-2. mRNA expression in vascular
endothelial cells, however, was not altered after P. urinaria or
Ellagic Acid treatment. Therefore, the anti-angiogenic eﬀect
of P. urinaria on vascular endothelial cells was most likely
mediated by a mechanism other than MMP transcriptional
regulation.
Because there exists a secretory function to allow rapid
mobilization and utilization of these crucial MMP-2 regu-
latory enzymes in the early phase of angiogenesis [43], we
focused on cellular secretions after P. urinaria or Ellagic
Acid treatment. Results showed that MMP-2 protein level in
the conditioned medium decreased dose-dependently in P.
urinaria or Ellagic Acid treated HUVECs, while the level of
MMP-2 proteins in the cells increased in a dose-dependent
manner. This suggests that P. urinaria and Ellagic Acid
can inhibit the secretion of MMP-2 in HUVECs. MMP-2
secretion itself is probably regulated by multiple pathways.
The detail mechanism still needs further investigation.
In conclusion as shown in Figure 7, a potent inhibitory
eﬀect of P. urinaria on MMP-2 activity, both in vivo and
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Figure 6: (a) Ellagic Acid dose-dependently inhibited the MMP-
2 activity in HUVECs. Conditioned media taken from cultures
of HUVECs, with or without the treatment of Ellagic Acid for
24h, were used for the gelatin zymography analysis. To study
the eﬀects of Ellagic Acid on the mRNA expression of MMP in
HUVECs, cells were treated with (b) Ellagic Acid for 24h and the
mRNAexpressionsofMMP-2,MMP-14,TIMP-2andGAPDHwere
determined by RT-PCR analysis. (c) Cells treated with Ellagic Acid
for 24h were processed for western blotting to analyze the protein
levels of MMP-2 in the conditioned media and cytosol.
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Figure 7: Schematic diagram illustrates the molecular mechanism
that is responsible for the anti-angiogenic eﬀect of P. urinaria and
Ellagic Acid.
in vitro, which may be one of the mechanisms leading to
the suppression of angiogenesis, was identiﬁed. The active
compound of P. urinaria is Ellagic Acid. The mechanisms
of extracellular suppression in MMP-2 activity go through
the inhibition of MMP-2 secretion from cells. P. urinariaEvidence-Based Complementary and Alternative Medicine 9
or Ellagic Acid could be considered for future clinical
development as an antitumor agent.
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